The DOI matches its Crossref record.
Inter‐laboratory and inter‐observer reproducibility of immunohistochemical assessment of the Ki‐67 labelling index in a large multi‐centre trial
Abstract
Proliferative activity of tumour cells, as assessed by the Ki‐67 labelling index, has been suggested as a potential prognostic indicator in many neoplastic diseases. Meaningful application of the immunohistochemically determined tumour cell growth fraction in clinical decision‐making requires information about its inter‐laboratory reproducibility. To assess the reproducibility of Ki‐67 determined growth fraction, a multi‐centre immunohistochemical trial was performed with 172 participating laboratories, each testing 30 different tissue samples. Evaluating 5160 Ki‐67 labelling indices with a newly developed tissue microarray, good inter‐observer reproducibility but high inter‐laboratory variability was found. Reassessment of all stainings revealed considerable inter‐laboratory differences in the intensity and frequency of labelled nuclei, suggesting that antigen retrieval or staining techniques are predominantly responsible for the inter‐laboratory variability found in this trial. Consequently, cut‐off levels for Ki‐67, suggested to distinguish prognostic subgroups in tumours, appear to have limited reproducibility in a multi‐centre approach. It is concluded that there is a need to standardize the immunohistochemical determination of the Ki‐67 labelling index when it is used as a prognostic indicator in surgical pathology. Copyright © 2002 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Dowsett, M., Nielsen, T. O., A'Hern, R., Bartlett, J., Coombes, R. C., Cuzick, J., Ellis, M., Henry, N. L., Hugh, J. C., Lively, T., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr393 · Cited by 1,977
Nielsen, T. O., Leung, S. C. Y., Rimm, D. L., Dodson, A., Acs, B., Badve, S., Denkert, C., Ellis, M. J., Fineberg, S., Flowers, M., et al. (2021) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djaa201 · Cited by 753
Self-citationWalker, R. A. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02514.x · Cited by 316
Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
Davey, M. G., Hynes, S. O., Kerin, M. J., Miller, N., & Lowery, A. J. (2021) · Cancers · doi:10.3390/cancers13174455 · Cited by 298
Arnold, R., Rinke, A., Klose, K.-J., Müller, H.-H., Wied, M., Zamzow, K., Schmidt, C., Schade-Brittinger, C., Barth, P., Moll, R., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00481-7 · Cited by 254
Artificial intelligence in digital breast pathology: Techniques and applications
Ibrahim, A., Gamble, P., Jaroensri, R., Abdelsamea, M. M., Mermel, C. H., Chen, P.-H. C., & Rakha, E. A. (2020) · The Breast · doi:10.1016/j.breast.2019.12.007 · Cited by 202
“Although this approach is well-validated and widely used, there is signi fi cant inter-observer variability in manual biomarker status assessment from IHC [45,46] suggesting an opportunity for machine-learning based systems to assist pathologists with biomarker status assessments.”
MethodAssessment of α-Synuclein Pathology: A Study of the BrainNet Europe Consortium
Alafuzoff, I., Parkkinen, L., Al-Sarraj, S., Arzberger, T., Bell, J., Bodi, I., Bogdanovic, N., Budka, H., Ferrer, I., Gelpi, E., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181633526 · Cited by 90
Development of a novel method for measuring in vivo breast epithelial cell proliferation in humans
Misell, L. M., Hwang, E. S., Au, A., Esserman, L., & Hellerstein, M. K. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-2228-5 · Cited by 24
Metadata
- Authors
- Mengel, M., von Wasielewski, R., Wiese, B., Rüdiger, T., Müller‐Hermelink, H. K., & Kreipe, H.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2002-08-27
- Volume
- 198
- Issue
- 3
- Pages
- 292-299
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2104586902
- Cited by
- 213
- References
- 0
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.